Veeda Clinical Research Limited is one of the largest independent CROs in India. Its offerings include a comprehensive portfolio of services across various steps of drug development throughout the global markets including North America, Europe and Asia.
The Global CRO market is set to reach $90bn+ by 2026 from the current ~$65B, on the back of increased outsourcing from pharma companies. India is projected to be the fastest growing CRO market, with a ~12% CAGR, on account of (i) increased interest and acceptability of India as an outsourcing destination due to successful large scale COVID-19 vaccine trials, favorable demographics (cost, english literacy, etc.), and diversity of volunteers required for trials (ii) increasing demand for outsourcing complex generic trials to competent CROs.
Apurva Shah, CEO
